Preface
Protein Pept Lett. 2024;31(1):2. doi: 10.2174/092986653101240120234231.NO ABSTRACTPMID:38444252 | DOI:10.2174/092986653101240120234231 (Source: Protein and Peptide Letters)
Source: Protein and Peptide Letters - March 6, 2024 Category: Biochemistry Authors: Ben M Dunn Source Type: research
In Silico Analysis of Natural Plant-Derived Cyclotides with Antifungal Activity against Pathogenic Fungi
CONCLUSION: These in silico studies can be applied for rapidly identifying putatively potent antifungal cyclotides for in vivo and in vitro experiments, which will ultimately be relevant in the agriculture and pharmaceutical sectors.PMID:38445693 | DOI:10.2174/0109298665295545240223114346 (Source: Protein and Peptide Letters)
Source: Protein and Peptide Letters - March 6, 2024 Category: Biochemistry Authors: Akshita Sharma Bisma Butool Pallavi Sahu Reema Mishra Aparajita Mohanty Source Type: research
Tribute to Prof. Ben M. Dunn: A Remarkable Biochemist and Editor-in-Chief of Protein & amp; Peptide Letters and Current Protein & amp; Peptide Science
Protein Pept Lett. 2024;31(1):1. doi: 10.2174/092986653101240120233748.NO ABSTRACTPMID:38444251 | DOI:10.2174/092986653101240120233748 (Source: Protein and Peptide Letters)
Source: Protein and Peptide Letters - March 6, 2024 Category: Biochemistry Source Type: research
Preface
Protein Pept Lett. 2024;31(1):2. doi: 10.2174/092986653101240120234231.NO ABSTRACTPMID:38444252 | DOI:10.2174/092986653101240120234231 (Source: Protein and Peptide Letters)
Source: Protein and Peptide Letters - March 6, 2024 Category: Biochemistry Authors: Ben M Dunn Source Type: research
In Silico Analysis of Natural Plant-Derived Cyclotides with Antifungal Activity against Pathogenic Fungi
CONCLUSION: These in silico studies can be applied for rapidly identifying putatively potent antifungal cyclotides for in vivo and in vitro experiments, which will ultimately be relevant in the agriculture and pharmaceutical sectors.PMID:38445693 | DOI:10.2174/0109298665295545240223114346 (Source: Protein and Peptide Letters)
Source: Protein and Peptide Letters - March 6, 2024 Category: Biochemistry Authors: Akshita Sharma Bisma Butool Pallavi Sahu Reema Mishra Aparajita Mohanty Source Type: research
Tribute to Prof. Ben M. Dunn: A Remarkable Biochemist and Editor-in-Chief of Protein & amp; Peptide Letters and Current Protein & amp; Peptide Science
Protein Pept Lett. 2024;31(1):1. doi: 10.2174/092986653101240120233748.NO ABSTRACTPMID:38444251 | DOI:10.2174/092986653101240120233748 (Source: Protein and Peptide Letters)
Source: Protein and Peptide Letters - March 6, 2024 Category: Biochemistry Source Type: research
Preface
Protein Pept Lett. 2024;31(1):2. doi: 10.2174/092986653101240120234231.NO ABSTRACTPMID:38444252 | DOI:10.2174/092986653101240120234231 (Source: Protein and Peptide Letters)
Source: Protein and Peptide Letters - March 6, 2024 Category: Biochemistry Authors: Ben M Dunn Source Type: research
In Silico Analysis of Natural Plant-Derived Cyclotides with Antifungal Activity against Pathogenic Fungi
CONCLUSION: These in silico studies can be applied for rapidly identifying putatively potent antifungal cyclotides for in vivo and in vitro experiments, which will ultimately be relevant in the agriculture and pharmaceutical sectors.PMID:38445693 | DOI:10.2174/0109298665295545240223114346 (Source: Protein and Peptide Letters)
Source: Protein and Peptide Letters - March 6, 2024 Category: Biochemistry Authors: Akshita Sharma Bisma Butool Pallavi Sahu Reema Mishra Aparajita Mohanty Source Type: research
Tribute to Prof. Ben M. Dunn: A Remarkable Biochemist and Editor-in-Chief of Protein & amp; Peptide Letters and Current Protein & amp; Peptide Science
Protein Pept Lett. 2024;31(1):1. doi: 10.2174/092986653101240120233748.NO ABSTRACTPMID:38444251 | DOI:10.2174/092986653101240120233748 (Source: Protein and Peptide Letters)
Source: Protein and Peptide Letters - March 6, 2024 Category: Biochemistry Source Type: research
Preface
Protein Pept Lett. 2024;31(1):2. doi: 10.2174/092986653101240120234231.NO ABSTRACTPMID:38444252 | DOI:10.2174/092986653101240120234231 (Source: Protein and Peptide Letters)
Source: Protein and Peptide Letters - March 6, 2024 Category: Biochemistry Authors: Ben M Dunn Source Type: research
In Silico Analysis of Natural Plant-Derived Cyclotides with Antifungal Activity against Pathogenic Fungi
CONCLUSION: These in silico studies can be applied for rapidly identifying putatively potent antifungal cyclotides for in vivo and in vitro experiments, which will ultimately be relevant in the agriculture and pharmaceutical sectors.PMID:38445693 | DOI:10.2174/0109298665295545240223114346 (Source: Protein and Peptide Letters)
Source: Protein and Peptide Letters - March 6, 2024 Category: Biochemistry Authors: Akshita Sharma Bisma Butool Pallavi Sahu Reema Mishra Aparajita Mohanty Source Type: research
Interleukin 6 Antagonists in Severe COVID-19 Disease: Cardiovascular and Respiratory Outcomes
Protein Pept Lett. 2024 Feb 19. doi: 10.2174/0109298665266730240118054023. Online ahead of print.ABSTRACTBACKGROUND: Inhibitors of interleukin 6 [IL-6] have been utilized to treat severe COVID-19 disease. Their immunosuppressive or immunomodulating impact may be beneficial in COVID-19.OBJECTIVES: To discuss the role of IL-6 inhibitors and assess various trials conducted to evaluate the efficacy of IL-6 inhibitors in COVID-19 disease.SUMMARY: Two of the most common causes of mortality in COVID-19-infected critically ill individuals are acute respiratory distress syndrome [ARDS] and multiorgan failure. Increased levels of in...
Source: Protein and Peptide Letters - February 20, 2024 Category: Biochemistry Authors: Shahzad Khan Source Type: research
Interleukin 6 Antagonists in Severe COVID-19 Disease: Cardiovascular and Respiratory Outcomes
Protein Pept Lett. 2024 Feb 19. doi: 10.2174/0109298665266730240118054023. Online ahead of print.ABSTRACTBACKGROUND: Inhibitors of interleukin 6 [IL-6] have been utilized to treat severe COVID-19 disease. Their immunosuppressive or immunomodulating impact may be beneficial in COVID-19.OBJECTIVES: To discuss the role of IL-6 inhibitors and assess various trials conducted to evaluate the efficacy of IL-6 inhibitors in COVID-19 disease.SUMMARY: Two of the most common causes of mortality in COVID-19-infected critically ill individuals are acute respiratory distress syndrome [ARDS] and multiorgan failure. Increased levels of in...
Source: Protein and Peptide Letters - February 20, 2024 Category: Biochemistry Authors: Shahzad Khan Source Type: research
Interleukin 6 Antagonists in Severe COVID-19 Disease: Cardiovascular and Respiratory Outcomes
Protein Pept Lett. 2024 Feb 19. doi: 10.2174/0109298665266730240118054023. Online ahead of print.ABSTRACTBACKGROUND: Inhibitors of interleukin 6 [IL-6] have been utilized to treat severe COVID-19 disease. Their immunosuppressive or immunomodulating impact may be beneficial in COVID-19.OBJECTIVES: To discuss the role of IL-6 inhibitors and assess various trials conducted to evaluate the efficacy of IL-6 inhibitors in COVID-19 disease.SUMMARY: Two of the most common causes of mortality in COVID-19-infected critically ill individuals are acute respiratory distress syndrome [ARDS] and multiorgan failure. Increased levels of in...
Source: Protein and Peptide Letters - February 20, 2024 Category: Biochemistry Authors: Shahzad Khan Source Type: research
Interleukin 6 Antagonists in Severe COVID-19 Disease: Cardiovascular and Respiratory Outcomes
Protein Pept Lett. 2024 Feb 19. doi: 10.2174/0109298665266730240118054023. Online ahead of print.ABSTRACTBACKGROUND: Inhibitors of interleukin 6 [IL-6] have been utilized to treat severe COVID-19 disease. Their immunosuppressive or immunomodulating impact may be beneficial in COVID-19.OBJECTIVES: To discuss the role of IL-6 inhibitors and assess various trials conducted to evaluate the efficacy of IL-6 inhibitors in COVID-19 disease.SUMMARY: Two of the most common causes of mortality in COVID-19-infected critically ill individuals are acute respiratory distress syndrome [ARDS] and multiorgan failure. Increased levels of in...
Source: Protein and Peptide Letters - February 20, 2024 Category: Biochemistry Authors: Shahzad Khan Source Type: research
